Shield Therapeutics PLC (LON:STX) Tim Watts updates investors on its track to launch Accrufer, its iron deficiency treatment, in the US by the end of next month.
Preparatory work on the launch has accelerated dramatically, the firms has established a US subsidiary and set up the necessary operating essentials for the launch.
Work is in progress on the product supply chain and logistics and all being well, launch stocks should be in its US wholesaler’s warehouses by mid-June.